IPO Buzz: Hyperliquid Strategies’ $1B Filing Sparks 15% HYPE Rally
Hyperliquid Strategies Inc. (HSI), formed from an $888 million reverse merger between Sonnet Biotherapeutics Holdings Inc. and Rorschach I LLC, has filed a Form S-1 registration with the U.S. Securities…